Biologics

Cellular Biomedicine Group partnered with GE Healthcare to accelerate its stem cell therapy manufacturing timeline.

Former North American Spine Society President William Watters, MD, of Houston Medical, discusses the biggest spine technology, clinical and business trends for 2018.

The FDA granted clearance for Mayo Clinic Center for Regenerative Medicine in Jacksonville, Fla., to treat patients with its stem cell production platform, according to The Florida Times-Union.

The FDA cleared ORTHOReBIRTH USA's ReBOSSIS. ORTHOReBIRTH develops orthopedic biologics.

Kleiner Device Labs initiated a full commercial launch of its spinal bone graft delivery tool.

Sealantis, the Haifa, Israel-based developer of absorbable surgical sealants and adhesives, received CE marking approval for its Seal-G Surgical Sealant. The CE marking will allow the product to be marketed in Europe and other countries.

Researchers at Osaka University in Japan used synovium-derived mesenchymal stem cells to develop a synthetic tissue to treat damaged cartilage, which previously had no effective therapies and was incurable. The first patient surgery was performed in the Phase III clinical…

RTI Surgical laid out its 2018 guidance and long-term financial goals.

Gulf Breeze, Fla.-based Andrews Institute for Orthopaedics and Sports Medicine is reporting positive results in its study to create new cartilage in the knee through stem cell injections, the Pensacola News Journal reports.

Little Rock, Ark.-based Baptist Health Spine Center physicians are encouraging patients to avoid surgery through the use of stem cell injections, according to Arkansas Matters.